| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 213 |
| 1 | METFORMIN ER 500 MG | 198 |
| 2 | METFORMIN ER 750 MG | 198 |
| 3 | INSULIN GLARGINE | 173 |
| 4 | DULAGLUTIDE | 161 |
| 5 | EMPAGLIFLOZIN | 142 |
| 6 | ORAL SEMAGLUTIDE | 89 |
| 7 | INSULIN LISPRO | 79 |
| 8 | SITAGLIPTIN | 77 |
| 9 | TIRZEPATIDE | 69 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0244 |
| 1 | EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE | 1 | 0.0081 |
| 2 | SOMAPACITAN-BECO | 1 | 0.0055 |
| 3 | EMPAGLIFLOZIN AND LINAGLIPTIN | 10 | 0.0051 |
| 4 | SITAGLIPTIN PHOSPHATE | 9 | 0.0033 |
| 5 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 10 | 0.0028 |
| 6 | INSULIN GLARGINE AND LIXISENATIDE | 9 | 0.0025 |
| 7 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 3 | 0.0024 |
| 8 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | 1 | 0.0023 |
| 9 | NATEGLINIDE | 3 | 0.0022 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 176 | 0.0016 |
| 1 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 2 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 30 | 0.0009 |
| 3 | Leptin Analog [EPC] | 1 | 0.0008 |
| 4 | GLP-1 Receptor Agonist [EPC] | 342 | 0.0008 |
| 5 | PCSK9 Inhibitor [EPC] | 18 | 0.0007 |
| 6 | Provitamin D2 Compound [EPC] | 20 | 0.0007 |
| 7 | Insulin Analog [EPC] | 251 | 0.0006 |
| 8 | Sulfonylurea [EPC] | 68 | 0.0006 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |